Optogenetics Using X-ray Stimulated Nanophosphors
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current optogenetic techniques are invasive and limited by the shallow penetration of visible light into tissue, restricting their application in clinical settings and depth of neural modulation.
Innovation Solution
The use of X-rays and ultrasound waves to stimulate light-emitting particles, such as nanophosphors or chemiluminescent agents, to emit visible light and modulate neuronal membrane potentials, allowing for deeper and non-invasive optogenetic control.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Illumination intensity
If visible light is used for optogenetic control, then neuronal membrane potential can be modulated, but the penetration depth into tissue is limited
Solution Approach 1:
The patent introduces light-emitting particles (nanophosphors or chemiluminescent agents) as intermediary substances that convert X-ray or ultrasound energy into visible light. These particles are delivered to the target neural tissue and act as local light sources, enabling deep tissue penetration without the limitations of external visible light sources. The particles mediate the energy conversion from penetrating radiation (X-ray/ultrasound) to the required optical stimulus for optogenetics.
Solution Approach 2:
The patent replaces the traditional mechanical/optical light delivery system (external light sources, optical fibers, implants) with a field-based approach using X-rays or ultrasound waves. These electromagnetic and acoustic fields can penetrate deep into tissue without physical contact or invasive implants, substituting the mechanical light delivery infrastructure with non-invasive field energy that is then converted to optical stimulation at the target site.
2Reliability
If traditional optogenetic methods are used, then neuronal control is achieved, but invasive procedures are required
Solution Approach 1:
Light-emitting particles serve as mediators that eliminate the need for invasive light source implantation. These particles are delivered systemically (e.g., via injection) to the target tissue, where they locally convert X-ray or ultrasound energy into light. This intermediary approach replaces invasive optical fiber or LED implants with non-invasive particle delivery and field-based stimulation.
Solution Approach 2:
The patent substitutes invasive mechanical light delivery systems (optical fibers, implanted LEDs) with non-invasive X-ray or ultrasound field delivery. The field-based approach penetrates tissue without physical intrusion, and the light-emitting particles convert this field energy to optical stimulation, eliminating the need for surgical implantation while maintaining precise neuronal control.
3Length of stationary object
If X-rays are used to stimulate light-emitting particles, then deep tissue optogenetics is enabled, but radiation exposure increases
Solution Approach 1:
The patent employs pulsed or periodic X-ray stimulation rather than continuous exposure. By delivering X-rays in controlled pulses synchronized with the optogenetic stimulation requirements, the system achieves the necessary cumulative light emission from nanophosphors while minimizing total radiation dose. The periodic action allows tissue recovery between pulses and reduces overall harmful exposure.
Solution Approach 2:
The patent optimizes X-ray parameters (energy level, pulse duration, intensity, frequency) to achieve the minimum effective dose required for sufficient light emission from nanophosphors. By carefully controlling these parameters, the system balances penetration depth and stimulation effectiveness against radiation exposure, using the lowest possible X-ray intensity and duration that still achieves the desired optogenetic effect.
4Ease of operation
If light-emitting particles are used for deep optogenetics, then non-invasive control is achieved, but device complexity increases
Solution Approach 1:
The patent employs multi-functional light-emitting particles that can respond to different types of stimulation (X-ray or ultrasound) and emit appropriate wavelengths for various optogenetic applications. These universal particles can be used across different experimental and clinical scenarios, reducing the need for multiple specialized systems and simplifying the overall complexity despite the advanced functionality.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables more precise and invasive-free optogenetic control at a microscopic or nanoscopic level, enhancing the depth of neural modulation and reducing the need for implanted light sources, thus expanding the scope of optogenetic applications.
Implementation Method 1
providing X-rays to the sample such that the X-rays cause the light-emitting particles to emit light
Implementation Method 2
providing ultrasonic waves to the sample causing a sonoluminescence effect within the sample and also causing the chemiluminescent agents to emit light
Data Source
AI summary
Methods and systems for performing optogenetics using X-rays or ultrasound waves are provided. Visible-light-emitting nanophosphors can be provided to a sample, and X-ray stimulation can be used to stimulate the nanophosphors to emit visible light. Alternatively, ultrasonic waves can be provided to the sample to cause sonoluminescence, also resulting in emission of visible light, and this can be aided by the use of a chemiluminescent agent present in the sample. The emitted light can trigger changes in proteins that modulate membrane potentials in neuronal cells.